Boston Biomedical

Latest Headlines

Latest Headlines

Top 10 late-stage cancer drugs in 2012

Thousands of experimental meds are winding their way through various stages of clinical trials today, and the largest category among the contenders is cancer drugs.

Dainippon bags Boston Biomedical and cancer stem cell tech in $2.6B buyout

Boston Biomedical's focus on targeting cancer stem cells has paid off.